Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_assertion type Assertion NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_head.
- NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_assertion description "[(i) hERG1 was expressed at high levels in 59% of primary PDAC; (ii) hERG1 blockade decreased PDAC cell growth and migration; (iii) hERG1 was physically and functionally linked to the Epidermal Growth Factor-Receptor pathway; (iv) in transgenic mice, ERG1 was expressed in PanIN lesions, reaching high expression levels in PDAC; (v) PDAC patients whose primary tumour showed high hERG1 expression had a worse prognosis; (vi) the ?-hERG1-MoAb could detect PDAC in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_provenance.
- NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_assertion evidence source_evidence_literature NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_provenance.
- NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_assertion SIO_000772 25719829 NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_provenance.
- NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_assertion wasDerivedFrom befree-2016 NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_provenance.
- NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_assertion wasGeneratedBy ECO_0000203 NP1266455.RAGWVRAcZRpXTMkL4bndij4-F5aVmDLugS6_vDhgumfxE130_provenance.